Rohto Pharmaceutical and Euglena Conclude a Capital and Business Alliance Agreement

 Rohto Pharmaceutical and euglena have signed a capital and business alliance agreement to realize a sustainable society.


Combining the strengths of Rohto Pharmaceutical, which has developed eye care, skin care, and oral medicine businesses mainly in the health and beauty care field, with the strengths of Euglena Co., Ltd., which has developed a healthcare business and a biofuel business using the microalgae Euglena, Promote collaboration in various business areas and research and development.

Comments

Popular posts from this blog

L'Oréal forms research and technology alliance with Israeli climate tech company

"THE SONOKO White Mask" for moisturizing and transparent skin of adults

L'Oreal Research & Innovation, Morishita Jintan Co., Ltd. and L'Oreal's first successful development of cutting-edge "active delivery capsules" made of useful ingredients for plant-derived cosmetics